SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Acquisition

8 Nov 2012 07:00

RNS Number : 6057Q
Xchanging PLC
08 November 2012
 



8 November 2012

 

Xchanging plc

Acquisition of Italian fund administration business AR Enterprise S.r.l.

 

 

 

Xchanging plc ('Xchanging'), the business process, procurement and technology services provider and integrator, today announces that its subsidiary, Kedrios S.p.A. ('Kedrios'), has acquired 100% of the share capital of AR Enterprise S.r.l. ('AR'). AR, based in Milan, is a leading provider of software packages and comprehensive IT solutions for the securities brokerage and asset management industry in Italy, with a customer base comprising more than 100 leading financial institutions.

 

Xchanging will combine the newly acquired AR business with Kedrios, which operates in the same business segment.

 

The acquisition will provide a significantly improved proprietary technology platform and a much improved customer base to Kedrios. Operating synergies will also lead to reductions in the combined cost base, with restructuring costs self-funded from existing and future cash flow generated by the combined business.

 

The acquisition will enable Xchanging to accelerate the profit growth of the combined business, creating a stronger profitable business with scale and the ability to compete successfully in the Italian financial services, technology services and business processing markets. It was planned that Kedrios would reach a breakeven run rate by the end of 2013; but without scale and significant investment in upgraded technology, its ability to sustain a strong competitive position in the long term would have remained weak.

 

The initial consideration is €12.85 million, payable in cash on completion, with further consideration contingent upon achieving defined performance criteria. The contingent payments comprise €3.21 million ("First Contingent Payment") payable in Q1 2014 and up to a maximum of €12.49 million ("Second Contingent Payment") payable by the end of Q2 2015, resulting in a total maximum consideration of up to €28.55 million.

 

Xchanging has acquired AR's gross assets of €6.3 million and net assets of €2.6 million. Revenues for Kedrios and AR in 2011 were €12.5 million and €14.9 million respectively. The pre-tax profit attributable to AR was €3.3 million for the year ended 31 December 2011, and averaged €2.6 million over the last 3 years. The acquisition is anticipated to be earnings accretive, on an adjusted basis, from 2013 onwards.

 

Immediately prior to the acquisition Xchanging recapitalised Kedrios with €12.85 million which diluted the shareholding of partner SIA S.p.A. ("SIA") from 49% down to 1.3%. This dilution contributes to the stated objective of simplifying Xchanging's corporate structure by reducing this minority interest significantly.

 

The contingent payments for the acquisition of AR are subject to achieving certain performance criteria as follows:

 

·; The First Contingent Payment is subject to certain technology migration criteria being achieved;

 

·; The Second Contingent Payment is subject to the achievement of certain operating profit targets of the combined business for the year ending 31 December 2014. The full payout would be made when the combined operating profit of Kedrios and AR reaches €12.5 million. This is payable in increments as follows:

a) Between €0.0 and €9.64 million will be paid pro rata for 2014 operating profit of between €0.0 million to €6.0 million; and

b) €0.30 will be paid for each incremental €1 of 2014 operating profit achieved above €6.0 million up to €8.0 million; and

c) €0.50 will be paid for each incremental €1 of 2014 operating profit achieved above €8.0 million up to €12.5 million.

 

The four majority shareholders of AR were also directors of AR. They will remain with the combined business to ensure continuity and to support achievement of the performance criteria described above. The four directors are: Stefano Brioschi, who will become co-CEO of the newly combined business, alongside the current Kedrios CEO; Peter Arnold, who will also become a director of the combined business; and Michele Hessel and Roberto Roncoroni who will continue to support the combined business.

 

Under the existing agreements with SIA, Xchanging requires SIA's approval should it wish to transfer ownership of its shares in Kedrios. With respect to SIA's remaining 1.3% shareholding in Kedrios, SIA have a put option which can be exercised from January 2014 and Xchanging have a call option which can be exercised from January 2016.

 

In a separate transaction Xchanging and SIA have agreed proposed amendments ('Amendments') to the transfer rights of Xchanging and the timing on when the put and call options can be exercised. These Amendments mean (i) that Xchanging would be able to transfer ownership of its shares in Kedrios without the approval of SIA; and (ii) in the event of such a transfer occurring, either party would be entitled to exercise their respective put or call option at that time.

 

SIA is classified as a related party by the UK Listing Authority as a result of their 49% shareholding in Kedrios immediately prior to the recapitalisation and acquisition. The Amendments are therefore classified as a related party transaction by the UK Listing Authority and are conditional on the approval of Xchanging shareholders at a general meeting of Xchanging.

 

A circular setting out further details of the Amendments, together with the notice to convene a general meeting and the form of proxy for use at the general meeting, will be posted to Xchanging shareholders as soon as practicable.

 

Commenting on today's announcement, Ken Lever, Xchanging's CEO said: "The opportunity to acquire AR has enabled us to resolve the weak strategic position of Kedrios and to create a strong combined business with scale and strong profitability. We are delighted to have this foundation from which to establish a market leading position in the industry in Italy."

 

Commenting on the acquisition, Stefano Brioschi, AR's CEO said: "We are delighted to become part of Xchanging. The combined market presence of AR and Xchanging will enable us to provide a better quality service to our combined customer base."

 

 

 

Enquiries

Xchanging plc Tel: +44 (0) 207 780 6999

David Bauernfeind, Chief Financial Officer

Alexandra Hockenhull, Head of Corporate Communications

and Investor Relations

 

Maitland Tel: +44 (0) 207 379 5151

George Hudson

Emma Burdett

Daniel Yea

 

Conference Call

David Bauernfeind and Alexandra Hockenhull will host a conference call for analysts and investors to discuss this announcement at 07:30 GMT on Thursday 8 November 2012. The conference call telephone number is +44 (0)1452 555 566 and conference ID is 59659384.

 

For individuals unable to participate in the conference call, a telephone replay will be available until Thursday 21 November 2012. Please telephone +44 (0)1452 550 000 (conference ID 59659384).

 

 

Xchanging

 

What we are

Xchanging provides business processing, technology and procurement services internationally for customers across multiple industries.

 

What we do

Xchanging brings innovation, thought leadership and passion to its customers' businesses so as to enhance performance and value. Our values are embedded into everything we do.

 

What we want to be

Xchanging wants to be regarded as the best provider in its chosen markets by delivering services that are recognised for outstanding quality, reliability and innovation.

 

www.xchanging.com

Cautionary Statement: 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Xchanging's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approval or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLFFIILTLDIIF
Date   Source Headline
24th Nov 20114:32 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSBAE Systems HR Contract Expiry
10th Nov 20111:05 pmRNSDirector/PDMR Shareholding
9th Nov 201111:06 amRNSFurther re Directorate Change
7th Nov 20117:01 amRNSDirectorate Change
7th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20117:00 amRNSDirectorate Change
24th Oct 20112:03 pmRNSHolding(s) in Company
29th Sep 20116:34 pmRNSRe Xchanging Broking Services
29th Sep 20112:43 pmRNSHolding(s) in Company
28th Sep 20113:15 pmRNSRe Xchanging Broking Services
27th Sep 20119:10 amRNSHolding(s) in Company
27th Sep 20117:00 amRNSRe US Workers' Compensation Business
16th Sep 201110:33 amRNSNotice of Interim Management Statement
31st Aug 20119:40 amRNSHolding(s) in Company
23rd Aug 20117:00 amRNSDirectorate Change
22nd Aug 20114:30 pmRNSHolding(s) in Company
17th Aug 20112:30 pmRNSContract Win
15th Aug 20113:06 pmRNSHolding(s) in Company
2nd Aug 20113:47 pmRNSChange of Director of Cambridge Solutions Limited
1st Aug 20117:00 amRNSHalf Yearly Report
1st Aug 20117:00 amRNSContract Win
1st Aug 20117:00 amRNSBank Refinancing
20th Jul 20117:00 amRNSResult of Postal Ballot
18th Jul 20112:57 pmRNSHolding(s) in Company
12th Jul 20117:00 amRNSNotice of Half Year Results
4th Jul 20112:23 pmRNSHolding(s) in Company
24th Jun 201112:23 pmRNSDirector/PDMR Shareholding
14th Jun 20111:19 pmRNSHolding(s) in Company
8th Jun 20114:41 pmRNSHolding(s) in Company
7th Jun 20117:00 amRNSBoard Appointments
1st Jun 20117:00 amRNSDisposal
27th May 20113:22 pmRNSHolding(s) in Company
18th May 20113:12 pmRNSResult of AGM
16th May 20117:00 amRNSInterim Management Statement
26th Apr 20111:19 pmRNSHolding(s) in Company
20th Apr 20119:46 amRNSAnnual Information Update
12th Apr 20119:27 amRNSDirector/PDMR Shareholding
8th Apr 20119:00 amRNSAnnual Financial Report
7th Apr 20115:54 pmRNSHolding(s) in Company
7th Apr 20117:33 amRNSXchanging Renews Australian Contract
6th Apr 201110:07 amRNSDirector/PDMR Shareholding
5th Apr 20113:21 pmRNSHolding(s) in Company
1st Apr 20113:03 pmRNSHolding(s) in Company
31st Mar 20119:02 amRNSBlocklisting Interim Review
28th Mar 20119:00 amRNSDavid Andrews Share Transfer
28th Mar 20119:00 amRNSHolding(s) in Company
24th Mar 20115:24 pmRNSHolding(s) in Company
22nd Mar 20119:41 amRNSHolding(s) in Company
15th Mar 201111:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.